ADVAIR HFA

GlaxoSmithKline LLC🇺🇸 United States

FDA Page

Effective Date: May 23, 2024
Approval ID: dfaca6f9-3277-47b2-319d-1377917cb54c
Products: 3 registered
Version: 37

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation useInitial U.S. Approval: 2000

Quick Stats

Total Products3

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.